Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Eur Rev Med Pharmacol Sci ; 28(10): 3523-3531, 2024 May.
Article in English | MEDLINE | ID: mdl-38856127

ABSTRACT

OBJECTIVE: This study aimed to evaluate the efficacy and safety of total glucosides of paeony (TGP) in patients with primary Sjögren's syndrome (pSS). PATIENTS AND METHODS: This study included 236 patients with pSS, including 118 TGP users and 118 non-users. Propensity score matching and Binary logistic regression analyses were used to minimize confounding factors and determine the association between TGP treatment and clinical variables. RESULTS: The baseline indexes of TGP users and non-users were basically the same. The median time of follow-up in the two groups was also similar (p < 0.05). Compared with non-users, TGP users showed higher rates of improvement in dry mouth and eyes and musculoskeletal involvement, as well as more significant reductions in serum alanine aminotransferase (ALT) and direct bilirubin (DBIL) levels after treatment. Logistic regression confirmed that the use of TGP was negatively correlated with the increase of ALT and DBIL in pSS patients, and the reduction in these variables was more pronounced after 2 years of treatment. The incidence of adverse reactions in the TGP users was 11.9%, which was compatible with those in non-users. CONCLUSIONS: TGP is often a safe option for treating pSS patients with musculoskeletal features and abnormal ALT levels. Besides, it can help improve dry mouth and dry eyes and decrease DBIL levels.


Subject(s)
Glucosides , Paeonia , Propensity Score , Sjogren's Syndrome , Humans , Sjogren's Syndrome/drug therapy , Paeonia/chemistry , Glucosides/therapeutic use , Glucosides/adverse effects , Middle Aged , Female , Male , Treatment Outcome , Adult , Plant Extracts/therapeutic use , Plant Extracts/adverse effects , Aged
2.
Lett Appl Microbiol ; 74(3): 429-443, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34890484

ABSTRACT

The edible mushroom Termitomyces is an agaric-type basidiomycete fungus that has a symbiotic relationship with fungus-growing termites. An understanding of the detailed development mechanisms underlying the adaptive responses of Termitomyces sp. to their growing environment is lacking. Here, we compared the transcriptome sequences of different Termitomyces sp. samples and link-stipe grown on fungus combs in situ and monocultured in vitro. The assembled reads generated 8052 unigenes. The expression profiles were highly different for 2556 differentially expressed genes (DEGs) of the treated samples, where the expression of 1312 and 1244 DEGs was upregulated in the Mycelium and link-stipe groups respectively. Functional classification of the DEGs based on both Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed an expected shift in fungal gene expression, where stress response genes whose expression was upregulated in link-stipe may adaptively be involved in cell wall hydrolysis and fusion, pathogenesis, oxidation-reduction, transporter efflux, transposon efflux and self/non-self-recognition. Urease has implications in the expression of genes involved in the nitrogen metabolism pathway, and its expression could be controlled by low-level nitrogen fixation of fungus combs. In addition, the expression patterns of eleven select genes on the basis of qRT-PCR were consistent with their changes in transcript abundance, as revealed by RNA sequencing. Taken together, these findings may be useful for enriching the knowledge concerning the Termitomyces adaptive response to in situ fungus combs compared with the response of monocultures in vitro.


Subject(s)
Agaricales , Isoptera , Termitomyces , Animals , Gene Expression Profiling , Symbiosis , Transcriptome
3.
Bone Joint Res ; 8(11): 550-562, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31832175

ABSTRACT

OBJECTIVES: MicroRNAs (miRNAs) have been reported as key regulators of bone formation, signalling, and repair. Fracture healing is a proliferative physiological process where the body facilitates the repair of a bone fracture. The aim of our study was to explore the effects of microRNA-186 (miR-186) on fracture healing through the bone morphogenetic protein (BMP) signalling pathway by binding to Smad family member 6 (SMAD6) in a mouse model of femoral fracture. METHODS: Microarray analysis was adopted to identify the regulatory miR of SMAD6. 3D micro-CT was performed to assess the bone volume (BV), bone volume fraction (BVF, BV/TV), and bone mineral density (BMD), followed by a biomechanical test for maximum load, maximum radial degrees, elastic radial degrees, and rigidity of the femur. The positive expression of SMAD6 in fracture tissues was measured. Moreover, the miR-186 level, messenger RNA (mRNA) level, and protein levels of SMAD6, BMP-2, and BMP-7 were examined. RESULTS: MicroRNA-186 was predicted to regulate SMAD6. Furthermore, SMAD6 was verified as a target gene of miR-186. Overexpressed miR-186 and SMAD6 silencing resulted in increased callus formation, BMD and BV/TV, as well as maximum load, maximum radial degrees, elastic radial degrees, and rigidity of the femur. In addition, the mRNA and protein levels of SMAD6 were decreased, while BMP-2 and BMP-7 levels were elevated in response to upregulated miR-186 and SMAD6 silencing. CONCLUSION: In conclusion, the study indicated that miR-186 could activate the BMP signalling pathway to promote fracture healing by inhibiting SMAD6 in a mouse model of femoral fracture.Cite this article: Bone Joint Res 2019;8:550-562.

4.
J Eur Acad Dermatol Venereol ; 33(1): 178-184, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30223307

ABSTRACT

BACKGROUND: Currently, many laboratories have switched the traditional screening algorithm (TSA) to reverse screening algorithm (RSA) for the efficiencies in high-volume syphilis screening. However, confusions have been arisen regarding this paradigm shift. OBJECTIVE: To compare the performance of two algorithms with head-to-head mode. METHODS: Sera screening for syphilis were tested in parallel with chemiluminescence immunoassay (CIA) and toluidine red unheated serum test (TRUST). CIA-reactive sera from the RSA were reflexively tested with TRUST and confirmed with Treponema pallidum particle agglutination assay (TPPA), while the TRUST-reactive serology from the TSA were afterwards tested with TPPA. RESULTS: A total of 110 663 serum samples were screened. The RSA identified 2259 (2.0%) CIA-reactive results, of which 377 (16.7%) showed TPPA nonreactive results, while the TSA identified 934 (0.8%) TRUST-reactive results, of which 67 (7.2%) showed TPPA-nonreactive results. Among the 2259 CIA-reactive results, 1392 (61.6%) were TRUST-nonreactive, of which 350 (25.1%) were TPPA-nonreactive. A total of 182 sera from the 350 TPPA-nonreactive sera were further tested by a second CIA (VITROS Syphilis TPA, VITROS TPA), of which 155 (85.2%) were nonreactive and 27 (14.8%) were reactive. The 27 VITROS TPA-reactive sera were further tested with a treponemal Western blot assay (Euroimmun IgG Western Blot, EuroWB), of which 11 (41%) were indeterminate, 6 (22%) were nonreactive and 10 (37%) were reactive. Among the 10 EuroWB-reactive sera, two seroconverted to TPPA 1:80+/- after 1-year follow-up. Of 867 CIA-reactive/TRUST-reactive results, 27 (3.1%) were TPPA-nonreactive. CONCLUSIONS: The RSA identified more patients with reactive treponemal serology. However, it also yielded an increased likely false-reactive rate compared with the TSA, especially those results with low index values and TRUST-nonreactive serology, were necessary to retest with a second treponemal test. Further testing results with TPPA, VITROS TPA and EuroWB suggested the false-reactive CIA screening results and the likely false-nonreactive TPPA results when the reactive treponemal results screened with RSA were to be identified.


Subject(s)
Algorithms , Syphilis Serodiagnosis , Syphilis/blood , Syphilis/diagnosis , Adult , Aged , Aged, 80 and over , Agglutination Tests , Antibodies, Bacterial/blood , Azo Compounds , Blotting, Western , False Negative Reactions , False Positive Reactions , Female , Humans , Luminescent Measurements , Male , Mass Screening/methods , Middle Aged , Treponema pallidum/immunology
5.
Allergol. immunopatol ; 45(6): 541-548, nov.-dic. 2017. tab, graf
Article in English | IBECS | ID: ibc-168461

ABSTRACT

Background: The aim of the current study is to evaluate the prevalence, severity and possible risk factors of systemic reactions (SRs) to subcutaneous allergen immunotherapy (SCIT) in children and adolescents with asthma in Hangzhou, east China's Zhejiang province. Methods: From January 2011 to December 2016, this survey analysed the SCIT-related SRs involving 429 patients (265 children and 134 adolescents) affected by allergic asthma. Recorded data included demographics, diagnosis, patient statuses, pulmonary function testing results before and after each injection, allergen dosage, and details of SRs. Results: All patients finished the initial phase and six patients withdrew during the maintenance phase. There were 2.59% (328/12,655) SRs in all injections (3.28% in children and 1.47% in adolescents); 15.62% (67/429) patients experienced SRs (18.49% children and 10.98% adolescents). There were 54.57% SRs of grade 1; 42.37% SRs of grade 2; 3.05% SRs of grade 3; and no grades 4 or grade 5 SRs occurred in patients. Most reactions were mild, and were readily controlled by immediate emergency treatment. There was no need for hospitalisation. The occurrence of SRs was significantly higher in children than that in adolescents (p < 0.01). A higher ratio of SRs was found among patients with moderate asthma. Conclusion: This retrospective survey showed that properly-conducted SCIT was a safe treatment for children and adolescents with asthma in Hangzhou, East China. Children and patients with moderate asthma may be prone to develop SRs (AU)


No disponible


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Immunotherapy/methods , Hypersensitivity/therapy , Asthma/therapy , Desensitization, Immunologic/methods , Infusions, Subcutaneous , China/epidemiology , Retrospective Studies , Dermatophagoides pteronyssinus/pathogenicity , Skin Tests
6.
Allergol Immunopathol (Madr) ; 45(6): 541-548, 2017.
Article in English | MEDLINE | ID: mdl-28629672

ABSTRACT

BACKGROUND: The aim of the current study is to evaluate the prevalence, severity and possible risk factors of systemic reactions (SRs) to subcutaneous allergen immunotherapy (SCIT) in children and adolescents with asthma in Hangzhou, east China's Zhejiang province. METHODS: From January 2011 to December 2016, this survey analysed the SCIT-related SRs involving 429 patients (265 children and 134 adolescents) affected by allergic asthma. Recorded data included demographics, diagnosis, patient statuses, pulmonary function testing results before and after each injection, allergen dosage, and details of SRs. RESULTS: All patients finished the initial phase and six patients withdrew during the maintenance phase. There were 2.59% (328/12,655) SRs in all injections (3.28% in children and 1.47% in adolescents); 15.62% (67/429) patients experienced SRs (18.49% children and 10.98% adolescents). There were 54.57% SRs of grade 1; 42.37% SRs of grade 2; 3.05% SRs of grade 3; and no grades 4 or grade 5 SRs occurred in patients. Most reactions were mild, and were readily controlled by immediate emergency treatment. There was no need for hospitalisation. The occurrence of SRs was significantly higher in children than that in adolescents (p<0.01). A higher ratio of SRs was found among patients with moderate asthma. CONCLUSION: This retrospective survey showed that properly-conducted SCIT was a safe treatment for children and adolescents with asthma in Hangzhou, East China. Children and patients with moderate asthma may be prone to develop SRs.


Subject(s)
Allergens/therapeutic use , Asthma/therapy , Desensitization, Immunologic/methods , Drug-Related Side Effects and Adverse Reactions/epidemiology , Adolescent , Age Factors , Allergens/immunology , Asthma/immunology , Child , Child, Preschool , China/epidemiology , Desensitization, Immunologic/adverse effects , Female , Humans , Injections, Subcutaneous , Male , Prevalence , Retrospective Studies , Risk Factors , Surveys and Questionnaires
7.
Transl Psychiatry ; 6(9): e892, 2016 09 13.
Article in English | MEDLINE | ID: mdl-27622936

ABSTRACT

Wnts-related signaling pathways have been reported to play roles in the pathogenesis of stress-induced depression-like behaviors. However, there is relatively few direct evidence to indicate the effect of Wnt ligands on this process. Here, we investigated the role of Wnts in mediating chronic restraint stress (CRS)-induced depression-like behaviors. We found that CRS induced a significant decrease in the expression of Wnt2 and Wnt3 in the ventral hippocampus (VH) but not in the dorsal hippocampus. Knocking down Wnt2 or Wnt3 in the VH led to impaired Wnt/ß-catenin signaling, neurogenesis deficits and depression-like behaviors. In contrast, overexpression of Wnt2 or Wnt3 reversed CRS-induced depression-like behaviors. Moreover, Wnt2 and Wnt3 activated cAMP response element-binding protein (CREB) and there was CREB-dependent positive feedback between Wnt2 and Wnt3. Finally, fluoxetine treatment increased Wnt2 and Wnt3 levels in the VH and knocking down Wnt2 or Wnt3 abolished the antidepressant effect of fluoxetine. Taken together, our study indicates essential roles for Wnt2 and Wnt3 in CRS-induced depression-like behaviors and antidepressant.


Subject(s)
Behavior, Animal , Depression/genetics , Hippocampus/metabolism , Stress, Psychological/genetics , Wnt2 Protein/genetics , Wnt3 Protein/genetics , Animals , Antidepressive Agents, Second-Generation/pharmacology , Cyclic AMP Response Element-Binding Protein/metabolism , Depression/metabolism , Fluoxetine/pharmacology , Gene Knockdown Techniques , Hippocampus/drug effects , Male , Mice , Neurogenesis/genetics , Restraint, Physical , Stress, Psychological/metabolism , Wnt Signaling Pathway , Wnt2 Protein/drug effects , Wnt2 Protein/metabolism , Wnt3 Protein/drug effects , Wnt3 Protein/metabolism
8.
Genet Mol Res ; 15(1)2016 Mar 31.
Article in English | MEDLINE | ID: mdl-27051016

ABSTRACT

The protective effect of procyanidine and its oligomers against high glucose-mediated oxidative stress injury in endothelial progenitor cells (EPCs), and effect of procyanidin on vascular endothelial growth factor receptor-2 (VEGFR-2) expression and downstream signal pathway were analyzed in vitro. Rat bone marrow mononuclear cells were isolated, cultured under normal and high glucose (HG) conditions, and the changes in cell morphology observed. The EPCs were identified, and the oxidative stress products produced by EPCs (under normal and HG conditions) were quantified. Subsequently, an appropriate number of EPCs were cultured with and without procyanidin (OPC), and the MDA concentration and relative expression of VEGFR-2, AKT, IκB-α, and nuclear factor (NF)-κB were detected 1, 3, 5, and 7 days post-culture. We observed minor (round, translucent, gradually adhering) and significant (fusiform morphology/pebble distribution) cell morphological changes 3 and 7 days post-culture, respectively. Apoptosis and oxidative stress product release in EPCs cultured with HG increased significantly compared to the control group (P < 0.05). The oxidative stress product generation and relative expression of VEGFR-2, AKT, IkB-α, and NF-κB were not significantly affected by OPC addition in normal glucose conditions (P > 0.05); alternately, products generated as a result of oxidative stress were significantly reduced, the relative expression of VEGFR-2, AKT, and NF-κB protein was upregulated, and that of IκB-α was downregulated (P < 0.05) in HG + OPC EPCs. Therefore, procyanidin may promote cell proliferation by alleviating oxidative damage to EPCs under HG conditions, and upregulating VEGFR-2 expression and its downstream signal pathway.


Subject(s)
Biflavonoids/pharmacology , Catechin/pharmacology , Endothelial Progenitor Cells/drug effects , Endothelial Progenitor Cells/metabolism , Glucose/pharmacology , Proanthocyanidins/pharmacology , Vascular Endothelial Growth Factor Receptor-2/metabolism , Animals , Cells, Cultured , Oxidative Stress/drug effects , Rats , Signal Transduction/drug effects
9.
Physiol Res ; 62(4): 395-403, 2013.
Article in English | MEDLINE | ID: mdl-23961899

ABSTRACT

To determine the effect of saturated hydrogen saline on lipopolysaccharide (LPS)-induced acute liver dysfunction, rats were divided into control, LPS, and LPS plus saturated hydrogen saline (LPS+H(2)) groups. Treatment with saturated hydrogen saline prolonged the median survival time and reduced liver dysfunction. Moreover, saturated hydrogen saline significantly reduced pathological alterations in liver tissues, the number of ballooned hepatocytes, serum tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 levels, and myeloperoxidase (MPO) and malondialdehyde (MDA) levels in liver tissues (P<0.05). Cell apoptosis was detected in liver tissues after LPS treatment, and attenuated by saturated hydrogen saline treatment. Saturated hydrogen saline also decreased phosphorylated extracellular signal-regulated kinase (p-ERK), phosphorylated Jun kinase (p-JNK), nuclear factor-kappa B (NF-kappaB), and second mitochondria-derived activator of caspase (Smac) levels, and increased p38 activation (P<0.05). Thus, saturated hydrogen saline may attenuate LPS-induced acute liver dysfunction in rats, possibly by reducing inflammation and cell apoptosis. Mitogen-activated protein kinase (MAPK), NF-kappaB, and Smac may contribute to saturated hydrogen saline-mediated liver protection.


Subject(s)
Hydrogen/pharmacology , Lipopolysaccharides , Liver Diseases/prevention & control , Liver/drug effects , Sodium Chloride/pharmacology , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins , Biomarkers/blood , Carrier Proteins/metabolism , Disease Models, Animal , Enzyme Activation , Extracellular Signal-Regulated MAP Kinases/metabolism , Interleukin-6/blood , JNK Mitogen-Activated Protein Kinases/metabolism , Liver/metabolism , Liver/pathology , Liver Diseases/etiology , Liver Diseases/metabolism , Liver Diseases/pathology , Male , Malondialdehyde/metabolism , Mitochondrial Proteins/metabolism , NF-kappa B/metabolism , Peroxidase/metabolism , Phosphorylation , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/blood , p38 Mitogen-Activated Protein Kinases/metabolism
10.
Lupus ; 20(7): 678-89, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21382916

ABSTRACT

The occurrence of systemic lupus erythematosus (SLE) involves a gene-environment interaction and epigenetic regulations, such as DNA methylation, may play important role in the etiology of SLE. Some neurotransmitters, such as serotonin, can regulate T- and B-cell proliferation via the 5-HT1A receptor and are involved in the pathology of SLE. The abnormal methylation of DNA has been reported in SLE, but there has been no study concerning the serotonin system. This study was conducted to explore the DNA methylation status of the promoter region of HTR1A (PR-HTR1A) and the level of HTR1A mRNA in the peripheral blood lymphocytes (PBLC) of SLE patients and healthy controls (HC). In this study, the DNA methylation status of PR-HTR1A and the level of HTR1A mRNA were detected in the PBLC of SLE patients and HC. The results showed significant hypomethylation of PR-HTR1A in SLE patients compared with HC. The patients also showed a significantly higher HTR1A mRNA level than did the controls. Relatively higher percentage of anti-histone antibodies in methylated SLE patients was found compared with unmethylated patients. Our results support the hypothesis that the hypomethylation of PR-HTR1A and overexpression of HTR1A might contribute to SLE. These results also reveal that epigenetic regulation via the serotonin system may contribute to SLE, and reveal the link between the brain and the immune system.


Subject(s)
Autoantibodies/blood , DNA Methylation , Lupus Erythematosus, Systemic/genetics , Receptor, Serotonin, 5-HT1A/genetics , Adolescent , Adult , Case-Control Studies , Epigenesis, Genetic , Female , Gene Expression Regulation , Histones/immunology , Humans , Lymphocytes/metabolism , Male , Middle Aged , Promoter Regions, Genetic , RNA, Messenger/metabolism , Young Adult
11.
Thorac Cardiovasc Surg ; 59(7): 443-5, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21442581

ABSTRACT

Three cases of children, aged 7, 12 and 13 years, respectively, with bronchial mucoepidermoid carcinoma are presented. All patients were primarily misdiagnosed as pneumonitis following common symptoms of prolonged fever, cough, expectoration, and indirect signs of bronchial obstruction by chest roentgenogram, before the tumours in the main bronchi were revealed by chest computed tomography and bronchoscopy. After undergoing lobectomy and systematic lymph node dissection, all three patients recovered uneventfully. Histologically, all the cases were low-grade mucoepidermoid carcinoma; one case additionally had mediastinal lymph node metastasis. The patients have remained in good health during a follow-up of between 1.5 and 6 years. Despite its extremely rare occurrence in childhood, the possibility of bronchial mucoepidermoid carcinoma should be kept in mind when encountering a child presenting with symptoms of recurrent pneumonia.


Subject(s)
Bronchial Neoplasms , Carcinoma, Mucoepidermoid , Adolescent , Biopsy , Bronchial Neoplasms/diagnostic imaging , Bronchial Neoplasms/pathology , Bronchial Neoplasms/surgery , Carcinoma, Mucoepidermoid/diagnostic imaging , Carcinoma, Mucoepidermoid/pathology , Carcinoma, Mucoepidermoid/surgery , Child , Diagnostic Errors , Female , Humans , Lymph Node Excision , Male , Pneumonectomy , Pneumonia/diagnosis , Predictive Value of Tests , Tomography, X-Ray Computed , Treatment Outcome
12.
Oncogene ; 29(39): 5416-26, 2010 Sep 30.
Article in English | MEDLINE | ID: mdl-20639902

ABSTRACT

Menin encoded by the multiple endocrine neoplasia type 1 (MEN1) gene is associated with chromatin and the nuclear matrix and exerts multiple biological functions including regulation of cell proliferation and adhesion. Men1 mutations increase the likelihood of lung cancer development in mice. Menin expression is reduced in certain human non-small cell lung cancer cells, and reduction of menin is closely correlated with increased lung cancer metastasis to lymph nodes. However, it is poorly understood whether menin affects migration of lung cancer cells. In this study, we show that menin-regulated A549 lung cancer cell migration, which was mediated by growth factor pleiotrophin (PTN) and its cell surface receptor, protein tyrosine phosphatase beta/zeta (RPTP ß/ζ). Ectopic menin expression significantly repressed PTN transcription, but indirectly inhibited RPTP ß/ζ expression through repressing PTN expression. Further studies revealed that menin-regulated cell migration through PTN/RPTP ß/ζ, in conjunction with integrin α(v)ß(3), focal adhesion kinase, phosphatidylinositol 3-kinase and phosphorylated extracellular signal regulated kinase 1/2. These findings provide mechanistic insights into the molecular basis for menin/PTN-mediated regulation of A549 lung cancer cell migration.


Subject(s)
Carrier Proteins/metabolism , Cell Movement/physiology , Cytokines/metabolism , Lung Neoplasms/genetics , Protein Tyrosine Phosphatases/metabolism , Proto-Oncogene Proteins/physiology , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Signal Transduction/physiology , Cell Movement/genetics , Humans , Integrin alphaVbeta3/genetics , Integrin alphaVbeta3/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Protein Tyrosine Phosphatases/genetics , Signal Transduction/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...